Research Topics
Species | Alexander I TrosterSummaryAffiliation: University of North Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
Neuropsychology of deep brain stimulation in neurology and psychiatryAlexander I Troster
Department of Neurology, University of North Carolina School of Medicine at Chapel Hill, 3114 Bioinformatics Building CB 7025, Chapel Hill, NC 27599 7025, USA
Front Biosci 14:1857-79. 2009..A minority of patients experience more widespread, persistent, or serious cognitive and psychiatric sequelae, although research to date has failed to identify reliable risk factors for such adverse events...
Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validationAlexander I Troster
Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7025, USA
Parkinsonism Relat Disord 11:367-73. 2005..We sought to develop an ET-specific measure that might be more sensitive, acceptable to patients, relatively brief, and easily used...
Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkersAlexander I Troster
Department of Neurology CB 7025, University of North Carolina at Chapel Hill, 3114 Bioinformatics Building, Chapel Hill, NC 27599 7025, USA
Neuropsychol Rev 18:103-19. 2008....
Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's diseaseAlexander I Troster
Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA
J Neurol Sci 248:62-7. 2006..Additionally, results are consistent with prior findings showing an association between the epsilon4 allele and earlier onset of PD and presence of dementia...
Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indicesAlexander I Troster
Department of Neurology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599 7025, USA
Arch Clin Neuropsychol 22:711-8. 2007..These data may be useful to researchers and clinicians interested in determining the statistical significance of changes in cognitive test performance in persons with PD over a 1- to 2-year interval...
Executive dysfunction and neuropsychiatric symptoms predict lower health status in essential tremorSteven Paul Woods
Department of Psychiatry, University of California, San Diego, School of Medicine, La Jolla, CA 92103, USA
Cogn Behav Neurol 21:28-33. 2008..To evaluate the hypothesis that increased neuropsychiatric distress and cognitive impairment are associated with lower perceived health status in essential tremor (ET)...
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesIrene Litvan
Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA
Mov Disord 27:349-56. 2012....
Declines in switching underlie verbal fluency changes after unilateral pallidal surgery in Parkinson's diseaseAlexander I Troster
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, USA
Brain Cogn 50:207-17. 2002....
Long-term efficacy of globus pallidus stimulation for the treatment of Parkinson's diseaseKelly E Lyons
Department of Neurology, University of Miami Medical Center, Miami, Fla, USA
Stereotact Funct Neurosurg 79:214-20. 2002..To determine the long-term efficacy and safety of globus pallidus internus (GPi) stimulation for Parkinson's disease (PD)...
Apolipoprotein E and dementia in Parkinson disease: a meta-analysisXuemei Huang
Department of Neurology, University of North Carolina School of Medicine, Chapel Hill 27599 7025, USA
Arch Neurol 63:189-93. 2006..To understand the relationship of apolipoprotein E (APOE) polymorphism to dementia in Parkinson disease (PD) because the APOE epsilon4 allele is linked to Alzheimer disease...
Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatologyAlexander I Troster
Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA
Stereotact Funct Neurosurg 80:43-7. 2003..Because depression is a potent correlate of QOL, and STN-DBS may be associated with changes in mood, this study sought to determine whether QOL improvement is a direct or indirect consequence of motor improvement...
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCIIrene Litvan
Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA
Mov Disord 26:1814-24. 2011....
A recommended scale for cognitive screening in clinical trials of Parkinson's diseaseKelvin L Chou
Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109 5316, USA
Mov Disord 25:2501-7. 2010..Widespread adoption of a single instrument such as the MoCA in clinical trials can improve comparability between research studies on PD...
Asymmetrical ventricular enlargement in Parkinson's diseaseXuemei Huang
Department of Neurology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599 7025, USA, and University Hospital, Vancouver, British Columbia, Canada
Mov Disord 22:1657-60. 2007..This is the first report to suggest the presence of asymmetrical ventricular enlargement in PD, findings that may be worthy of further study...
Scales to assess psychosis in Parkinson's disease: Critique and recommendationsHubert H Fernandez
Department of Neurology, McKnight Brain Institute University of Florida, Gainesville, Florida 32611, USA
Mov Disord 23:484-500. 2008..The CGIS is suggested as a secondary outcome scale to measure change and response to treatment over time...
Manganese accumulation in the olfactory bulbs and other brain regions of "asymptomatic" weldersSuman Sen
Department of Neurology, University of North Carolina at Chapel Hill, North Carolina 27599, USA
Toxicol Sci 121:160-7. 2011..Further investigations of subclinical Mn exposure are warranted...
